Boardroom Paralysis in Switzerland
One in three audited Swiss SMEs has no valid signature if its principal director dies
A national analysis of all 432,445 active companies in the Swiss Commercial Register finds that 32% of audited SMEs — and 41% in French-speaking Switzerland — would be unable to execute a single legally binding act the day their principal signatory dies. The fragility is structural, observable in open data today, and concentrated along the country's linguistic divide.
Coverage. 432'445 active companies analysed across all 26 cantons; 89% board-verified against the Commercial Register. Analytic subset: 38'913 audited companies. Data as of June 2026.
Executive Summary
Swiss company law lets a board define how the company signs. The most common arrangement — a single director with individual signature, or two directors who can only sign jointly — is efficient until the principal signatory dies. At that moment the company can no longer execute any new legally binding act: contracts, hires, credit lines and banking changes are all suspended until the gap is resolved through the courts.
ValIndex analysed the signing structure of every active company in the Swiss Commercial Register across all 26 cantons. Among the 38,913 audited companies (a proxy for ≥10 employees under art. 727 CO), 12,362 — 32% — would have no viable signature pair the day their principal signatory dies. By construction, none of them holds an individual backup signature.
The exposure is not evenly spread. French-speaking Switzerland runs at a 41% risk rate, 2.5× the German-speaking cantons, with Ticino close behind at 38%. Sàrl/GmbH companies carry a sole-director rate twice that of SA/AG (44% vs 22%). The pattern tracks legal-form choice and board size — structural characteristics recorded in the public register — rather than any measure of company performance.
The three failure modes
32% of 38'913 audited companies (12'362) sit in one of three failure modes — none with a viable backup signature.
T1Sole director
A single board member with individual signature. No registered deputy, no collective pair in reserve. If this person dies, the company has no legal representative.
T2aFalse redundancy
A two-person board where one signs individually and the other only jointly. No non-board signatory exists. After the individual signatory dies, the survivor has no one to co-sign with.
T3aFragile duo
A two-person board where both members can only sign jointly. A single death leaves no one able to sign.
The Röstigraben, in governance data
Hover any canton. Shading runs from 11% (palest) to 52% (deepest). The Latin-speaking cantons of western and southern Switzerland form a near-contiguous high-exposure band.
Risk of boardroom paralysis among audited, active companies, by canton (T1+T2a+T3a). The Latin-speaking cantons of western and southern Switzerland form a near-contiguous high-exposure band — the Röstigraben, visible in governance data.
All 26 cantons, ranked
The gradient is sharp and consistent. The seven highest-exposure cantons are all French- or Italian-speaking; apart from the micro-canton of Uri (n=84), every German-speaking canton sits below 23%. The most and least exposed cantons differ nearly fivefold (Fribourg 52% vs Aargau 11%).
Read the full study — free
The structural breakdown, the legal mechanism and case law, scope, implications and full methodology — plus an alert on every new ValIndex study.
Free. New studies + the weekly pulse. Unsubscribe anytime.
Cite this study
ValIndex (2026). Boardroom Paralysis in Switzerland — National study. ValIndex Research, June 2026. https://valindex.ch/en/research/board-paralysis-2026/
According to ValIndex's 2026 national study, 32% of audited Swiss SMEs — and 41% in French-speaking Switzerland — would be unable to sign a single legally binding act if their principal signatory died (data as of June 2026).
Get the next study first
Be alerted to every new ValIndex study — plus the weekly Market Pulse: Swiss M&A signals, succession data, and commercial-register intelligence. Free, straight from the source.
Free. New studies + the weekly pulse. Unsubscribe anytime.